CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Alavert Allergy and Congestion D-12 hour

Loratadine and pseudoephedrine sulfate· ingredient loratadineOther antihistamines for systemic use· LORATADINE 5 mg/1; PSEUDOEPHEDRINE SULFATE 120 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.80184
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per EA — the trend nobody else shows. 7 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other loratadine products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.

ProductNADAC / EAvs this
basic care childrens allergy relief$0.04072−$0.76110
24 / 7 Life Non-Drowsy Allergy Relief$0.05293−$0.74890
Alavert Allergy$0.51467−$0.28720
Basic Care Childrens Allergy Relief$0.52258−$0.27930
allergy congestion relief$0.58514−$0.21670

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.